Efficacy of a Structured Exercise Program for Improving Functional Capacity and Quality of Life in Patients with Stage 3 and 4 Sarcoidosis A RANDOMIZED CONTROLLED TRIAL

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 38, Issue 2, 2019, Pages 124-130

  Naz, Ilknur ^a   Ozalevli, Sevgi ^b   Ozkan, Serir ^c   Sahin, Hulya ^c  

^a IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c Dr Suat Seren Chest Diseases and Thoracic Surgery Research and Training Hospital   (Turkey)

Author keywords

6 min walk test; Exercise program; quality of life; sarcoidosis

Indexed keywords

METHOTREXATE;

ABDUCTION; ADULT; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD GAS ANALYSIS; BODY MASS; BODY PLETHYSMOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSING CAPACITY FOR CARBON MONOXIDE; DYSPNEA; EXERCISE; FATIGUE SEVERITY SCALE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; GRIP STRENGTH; HEART RATE; HIP FLEXION ANGLE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LOWER LIMB; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MAXIMAL EXPIRATORY PRESSURE; MAXIMAL INSPIRATORY PRESSURE; MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; MENTAL HEALTH; MUSCLE STRENGTH; PHYSICAL ACTIVITY; PLETHYSMOGRAPHY; PULSE OXIMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SARCOIDOSIS; SHORT FORM 36; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TOTAL LUNG CAPACITY; TRAINING; TREADMILL EXERCISE; WALKING DISTANCE; COMPLICATION; EXERCISE TOLERANCE; FOLLOW UP; KINESIOTHERAPY; LUNG; LUNG DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 85062385789     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0000000000000307     Document Type: Article

References (39)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med 1999;160: 736-755
2. Jones N, Mochizuki M. Sarcoidosis: epidemiology and clinical features. Ocul Immunol Infl amm. 2010;18: 72-79
3. Spruit MA, Thomeer MJ, Gosselink R, et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax. 2005;60 (1): 32-38
4. Wirnsberger RM, Drent M, Hekelaar N, Breteler MH. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J. 1997;10: 1450-1455
5. Delobbe A, Perrault H, Maitre J, et al. Impaired exercise response in sarcoid patients with normal pulmonary function. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19 (2): 148-153
6. Sharma OP. Fatigue in sarcoidosis: incompletely understood, inadequately treated. Curr Opin Pulm Med. 2012;18: 470-471
7. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188 (8): e13-e64
8. Lacasse Y, Goldstein R, Lasseron TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4: CD003793
9. Naji NA, Connor MC, Donnely SC, McDonnell TJ. Effectiveness of pulmonary rehabilitation in restrictive lung disease. J Cardiopulm Rehabil. 2006;26 (4): 237-243
10. Jastrzebski D, Gumola A, Gawlik R, Kozielski J. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol. 2006;57: 139-148
11. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63: 549-554
12. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13 (3): 394-399
13. Salhi B, Troosters T, Behaegel M, Joos G, Derom E. Effects of pulmonary rehabilitation in patients with restrictive lung diseases Chest. 2010;137: 273-279
14. Ferreira A, Garvey C, Connors GL, et al. Pulmonary rehabilitation in interstitial lung disease: benefi ts and predictors of response Chest. 2009;135 (2): 442-447
15. Kozu R, Jenkins S, Senjyu H. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2011;16: 1196-1202
16. Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine. American College of Sports Medicine position stand: quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fi tness in apparently healthy adults: guidance for prescribing exercise Med Sci Sports Exerc. 2011;43 (7): 1334-1359
17. Crouch R. Physical and respiratory therapy for the medical and surgical patient. In: Hodkin JE, Celli BR, Connors GL, eds. Pulmonary Rehabilitation: Guidelines to Success. 4th ed. Maryland Heights, MO: Mosby Elsevier; 2009: 161
18. Dowman L, McDonald CF, Hill C, et al. The benefi ts of exercise training in interstitial lung disease: protocol for a multicentre randomized controlled trial. BMC Pulm Med. 2013;13: 8
19. ATS Statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166: 111-117
20. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J. 2005;26 (1); 153-161
21. Stenton C. The MRC breathlessness scale. Occup Med (Lond) 2008;8 (3): 226-227
22. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14: 377-381
23. Armutlu K, Korkmaz NC, Keser I, et al. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients Int J Rehabil Res. 2007;30 (1): 81-85
24. American Thoracic Society/European Respiratory Society. ATS/ ERS statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166: 518-624
25. Coldwells A, Atkinson G, Reilly T. Sources of variation in back and leg dynamometry. Ergonomics. 1994;73: 79-86
26. Polatli M, Yorgancioǧlu A, Aydemir Ö, et al. [Validity and reliability of Turkish version of St. George's Respiratory Questionnaire] Tuberk Toraks. 2013;61 (2): 81-87
27. Koçyiǧit H, Aydemir Ö, Fişek G, Ölmez N, Memis A. [Validity and reliability of Turkish version of Short form SF-36]. Ilaç ve Tedavi Dergisi. 1999;12: 102-106
28. Aydemir Ö, Güvenir T, Küey L, Kültür S. The reliability and validity of Turkish form of Hospital Anxiety and Depression Scale J Turk Psychiatry. 1997;8: 280-287
29. Moller DR. Systemic sarcoidosis. In: Fishman AP, Elias JA, eds. Fishman's Pulmonary Diseases and Disorders. 4th ed. New York City, NY: McGraw-Hill Medical; 2008: 1125-1142
30. Marcellis RG, Lenssen AF, Kleynen S, de Vries J, Drent M. Exercise capacity, muscle strength and fatigue in sarcoidosis: a follow-up study. Lung. 2013;191: 247-256
31. Akkoca Ö, Çelik G, Ulger F, et al. Exercise capacity in sarcoidosis: study of 29 patients. Med Clin (Barc). 2005;124 (18): 686-689
32. Swigris JJ, Brown KK, Make BJ, Wamboldt FS. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med. 2008;102: 1675-1680
33. Marcellis RG, Van der Veeke M, Mesters I, et al. Does physical training reduce fatigue in sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis. 2015;32 (1): 53-62
34. Strookappe B, Elfferich M, Swigris J, et al. Benefi ts of physical training in patients with idiopathic or end stage sarcoidosis-related pulmonary fibrosis: a pilot study. Sarcoidosis Vasc Diffuse Lung Dis. 2015;32 (1): 43-52
35. Swigris JJ, Wamboldt FS, Behr J, et al. The six minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax. 2010;65 (2): 173-177
36. Polkey MI, Spruit MA, Edwards LD, et al. Six minute walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med. 2013;187 (4): 382-386
37. Baydur A, Alsalek M, Louie SG, Sharma OP. Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis Chest. 2001;120: 102-108
38. Kabitz HJ, Lang F, Walterspacher S, Sorichter S. Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. Chest. 2006;130: 1496-1502
39. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA Health-related quality of life of persons with sarcoidosis. Chest 2004;125: 997-1004